Navigation Links
Savient Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference on November 18th
Date:11/13/2008

EAST BRUNSWICK, N.J., Nov. 13 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that Christopher Clement, President and Chief Executive Officer of Savient Pharmaceuticals will present a corporate update at the upcoming Lazard Capital Markets 5th Annual Healthcare Conference.

The presentation is scheduled to begin on Tuesday, November 18, 2008 at 9:25 a.m. ET. The Conference will be held at the St. Regis Hotel in New York City November 18-19, 2008.

Individuals can listen to a live webcast of the presentation by logging on to the Investor Relations section of Savient Pharmaceuticals' web site, http://www.savient.com. A replay of the webcast will be available on the company's web site for 30 days.

ABOUT SAVIENT PHARMACEUTICALS, INC.

Savient Pharmaceuticals is a biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets. The company's product development candidate, pegloticase for treatment-failure gout, has reported positive Phase 1, 2 and 3 clinical data. Patient dosing in the Phase 3 clinical studies began in June 2006; patient enrollment was completed in March 2007; and the Phase 3 clinical studies were completed in October 2007 and the BLA was filed with the FDA in October 2008. Savient has exclusively licensed worldwide rights to the technology related to pegloticase, formerly referred to as Puricase(R), from Duke University and Mountain View Pharmaceuticals, Inc. Savient's experienced management team is committed to advancing its pipeline and expanding its product portfolio by in-licensing late-stage compounds and exploring co-
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results
2. Savient Submits Biologics License Application (BLA) for pegloticase
3. Savients Pegloticase Data in Treatment-Failure Gout Patients Presented at 72nd Annual Meeting of the American College of Rheumatology Conference
4. Savient Pharmaceuticals to Hold Third Quarter 2008 Financial Results Conference Call on Thursday, November 6, 2008
5. Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results
6. ISTA Pharmaceuticals Files New Drug Application with U.S. FDA for Bepreve(TM)
7. Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results
8. Chemical Engineering Conference Highlights Energy, Biomedicine, Pharmaceuticals, Sustainability and Centennial
9. Potentia Pharmaceuticals Appoints Johanna M. Seddon, M.D. and Janet Stoltz Sunness, M.D. to Scientific Advisory Board
10. Nventa Biopharmaceuticals Announces Third Quarter 2008 Financial Results and Recent Corporate Highlights
11. Amylin Pharmaceuticals Announces Strategic Restructuring and Workforce Reduction

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... 2009 at 4:30 p.m. Eastern Time , BOTHELL, WA...oGenex Pharmaceuticals, Inc. ("OncoGenex" or the "...d financial results for the third quarter and nine...Company,s highlights for the third quarter of 2009... the operations of OncoGenex Technologies Inc. ("O...
(Date:11/5/2009)...rstCall/ -- Wound Management Technologies, Inc., (...Letter of Intent to purchase all healthcare-relate... Bulletin Board: VHGI). The deal provides for VHGI... shares of WNDM and a royalty agreement for revenu...eing acquired from VHGI. WNDM closed at $2.00 pe...
(Date:11/5/2009)...swire-Asia-FirstCall/ -- BMP Sunstone,Corporation ... today announced,that the Company plans to release...ovember 9, 2009, after the market closes. , ... pm ET on November 9, 2009,to discuss third quarte...dialing 1-888-713-4211 or 1-617-213-4864 for inter...
(Date:11/4/2009)...will be presented on November 19 and is of interes...rocessing, will deal with the application of the R...ro scale flow chemistry equipment. Professor Ley,...d with several prestigious prizes and awards, incl... Columbia, MD (PRWEB) Nove...
Breaking Biology Technology:OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3BMP Sunstone to Report Third Quarter 2009 Financial Results 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3
...,Transformation, Not Transactions, as the Necessar...WASHINGTON, Oct. 2 Deloitte & Touche USA LLP Life... will lead a discussion on,the intricacies of conv...idst increased competition, R&D stagnation, expand...h care costs, companies in all sectors,of the life...
...T, Calif., Oct. 2 Kiwa,Bio-Tech Products Group Co...ed that the Tianjin Kiwa Feed Limited Liability Co...ped 2,700 tons of animal feed during the,month of ...stated, "We are pleased with the,growth in volume ... tons,during the third quarter compared to approxi...
...t. 2 /PRNewswire/ - Respironics, Inc. (Nasdaq:,RES...e outstanding shares,of Apollo Light Systems, Inc....ing manufacturer of light therapy systems for mela...ders. Operating under the name Apollo Health,the c...nnual revenues of,approximately $5 million. The ba...
Other Biology Technology:Deloitte Leadership Offers Crucial Convergence Considerations for Life Sciences Companies 2Deloitte Leadership Offers Crucial Convergence Considerations for Life Sciences Companies 3Deloitte Leadership Offers Crucial Convergence Considerations for Life Sciences Companies 4Kiwa Bio-Tech Ships 2,700 Tons of Bio-feed in One Month 2Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market 2Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market 3
(Date:11/4/2009)...PORTOLA VALLEY, Calif., Oct. 19 Sp...ecular sensing and imaging devices which shed ligh...at it has signed exclusive distribution deals for ...ors. The markets covered include Australia, New Z...elux), Suriname, Italy, France, Spain, Portugal, P...
(Date:11/4/2009)...REDWOOD CITY, Calif., Oct. 20 Digi... and authentication solutions, today announced tha...-sale (POS) software for quick-service restaurants...eir NextGen POS and Classic POS solutions. WAND,s ...ometrics to boost cashier accountability and deter...
(Date:11/4/2009)...RIDGE, N.Y., Oct. 21 What,s the co...enting accidental death resulting from prescriptio...with good intentions, however, may be unaware that...ng their teens from the ticking timebomb of prescr...ader in premium-quality medical supplies, has form...
Breaking Biology News(10 mins):Spectros Signs New International Distribution Deals 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Availity Provides Real Time Access to WellCare 55281 1Availity Provides Real Time Access to WellCare 55281 2SamarionSolution Installed in Covington Retirement Community 55279 1SamarionSolution Installed in Covington Retirement Community 55279 2Fast Forward LLC and Amplimmune Inc Join Forces to Speed New Treatments to People with MS 13684 1Fast Forward LLC and Amplimmune Inc Join Forces to Speed New Treatments to People with MS 13684 2Fast Forward LLC and Amplimmune Inc Join Forces to Speed New Treatments to People with MS 13684 3Fast Forward LLC and Amplimmune Inc Join Forces to Speed New Treatments to People with MS 13684 4
...inceton biologist reports at AAAS on partnership w... endangered Grevy,s zebra conservation , The Grevy...e family in the world, with an estimated 2000 left...n the Samburu region of northern Kenya, most of th...ve partnership between Princeton University and Sa...
... organism widely used for genetics-versus-environm...dogs, humans and other species whose entire genome...onsortium,s annual meeting in Bloomington this wee...cientists announced they,ve completed a "shotgun" ...it,s better known to high school biology students....
...n may cringe at the idea, but sperm-producing stem...n in the lab, and frozen for future use. A team in...togonial stem cells from cows and cultured them in... could be done for men. "This is a very promising ...motherapy," Dirk de Rooij of Utrecht University, N...
Other Biology News:Bringing the zoos to the zebras 2Bringing the zoos to the zebras 3Genome sequencing is for ecologists, too 2Testes to incubate stem cells 2
Invitrogen Magnetic Stand from Invitrogen
H2A.X Phosphorylation Assay Kit (Flow Cytometry) from Upstate
H2A.X Phosphorylation Assay Kit (Chemiluminescence Detection) from Upstate
...-level automated perfusion system. For real-time o...ysiology, biophysics, electrochemistry, or general...ase reproducibility with 10 millisecond accuracy ...icroprocessor-based for accuracy and flexibility ...
Biology Products: